Precision Medicine

By Charles Alessi 02:50 am May 19, 2020
Precision medicine’s equivalent for people who are not necessarily ill, precision health, is only now starting to be developed. 
By Kat Jercich 12:03 pm May 14, 2020
The New York-based company claims its platform can be used to more accurately monitor efficacy of immunotherapy.
Tech optimization: Unlocking the promise of precision medicine
By Bill Siwicki 12:35 pm May 12, 2020
In this special report, seven experts in personalized medicine – from Accenture, CereCore, Chilmark Research, Deloitte and Orion Health – offer best practices for optimizing technology to help health systems advance innovation.
Cleveland Clinic COVID-19 research effort to rely on EHRs, analytics

The main campus of the Cleveland Clinic.

By Fred Bazzoli 10:30 am April 24, 2020
The organization, looking for ways to treat pathogens, will mine electronic health records of COVID-19 patients and use analytics to expedite research to find optimal treatment approaches.
By Mike Miliard 03:48 pm April 17, 2020
"We see an enormous opportunity to enhance disease tracking for improved population health during the COVID-19 pandemic," said Scripps Research Translational Institute's Dr. Eric Topol.
By Dean Koh 03:08 am February 19, 2020
Update: The HIMSS Global Conference in Orlando has been canceled due to the coronavirus. Read more here.
By Jonah Comstock 07:00 am February 18, 2020
The pilot showcases an approach to AI integration that keeps impact on the radiologist's workflow to a minimum.
By Benjamin Harris 10:55 am February 10, 2020
Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
By Mike Miliard 02:26 pm January 30, 2020
The five-year project will focus on enabling faster medical research innovations, protecting against global health crises and improving access to care, the company says.
By Nathan Eddy 10:57 am January 23, 2020
Artificial intelligence will also continue to be a big focus, as it becomes more clear which startups are succeeding in their initial target sectors. VCs are also eyeing genomics analytics tools, as well as other more practical technologies.